Predicine, a molecular information company based in Silicon Valley, has developed a portfolio of regulated liquid biopsy genomic products to help advance the science of precision medicine in cancer. Its patented GeneRADAR is a RNA + DNA-based liquid biopsy test for early cancer detection, disease monitoring and minimal residual disease assessment. It offers a 600 gene-panel to facilitate biomarker-driven patient enrollment in clinical trials. With its vast data sets and advanced analytics, Predicine partners with 30+ biopharmas to support their clinical trials in US, EU, Australia and China. It operates in US and China.
Predicine Address
3555 Arden Road Hayward, CA United States
Predicine Email
Past Companies
Predicine IncSenior Scientist
Stanford UniversityPostdoctoral Researcher
University of Southern CaliforniaPostdoctoral associate